Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03099434

Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
775 (actual)
Sponsor
Johns Hopkins University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This pilot study will be a clinical trial to test the feasibility and effectiveness of an educational intervention and a mobile health intervention in adults with end stage renal disease (ESRD) who have not yet identified a potential live donor.

Detailed description

Transplant candidates are hesitant to discuss their illness and the difficulties associated with dialysis, and are therefore reluctant to pursue live donor kidney transplant (LDKT). The investigators will conduct a prospective 3-arm randomized controlled trial with two novel interventions to increase live donation. Arm 1 includes LDC program and the Facebook app, Arm 2 includes just the Facebook app, and Arm 3 includes standard of care. The investigators primary objective is to demonstrate the the effectiveness of these interventions in increasing live donor transplantation rates for candidates with no prior potential live donor.

Conditions

Interventions

TypeNameDescription
BEHAVIORALFacebook AppThis web-based mobile application allows candidates to write a simple and effective story to share with their previously built network on Facebook to help share their story and identify a potential live donor.
BEHAVIORALLive Donor Champion + Facebook AppA "Live Donor Champion" (LDC) is a friend, family member, or community member who serves as an advocate for the candidate in their pursuit of live donation. The investigators have developed a six-month program that provides education and advocacy training to waitlist candidates and their LDCs.

Timeline

Start date
2017-04-01
Primary completion
2026-12-07
Completion
2026-12-07
First posted
2017-04-04
Last updated
2025-12-08

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03099434. Inclusion in this directory is not an endorsement.